← Leaderboards
Juan Luis Vivero-Escoto
University Of North Carolina Charlotte
$3,008,342
Attributed
$3,008,342
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $946.7K · FY2015–25$1M$750K$500K$250K$0
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,008,342 · 4
By mechanism
R01$1,611,629 · 1
R15$887,479 · 2
R16$509,234 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of North Carolina Charlotte
Same institution · by research overlap
- Kirill A Afonin$3,755,928
- Morgan Brittany Johnson$1,201,075
- Ian Marriott$5,101,438
- Yelixza Avila$77,480
Others in their field
Top investigators on “Nanoparticle”
- David Heimbrook · Leidos Biomedical Research, Inc.$67,480,937
- Ralph Weissleder · Massachusetts General Hospital$52,944,531
- Robert J Hamers · University Of Wisconsin-Madison$40,936,500
- Gang Bao · Georgia Institute Of Technology$28,866,343
- Barton F Haynes · Duke University$28,645,614
- Bala Raja · Luminostics, Inc.$28,624,460
Research focus
NanoparticleResistanceTechnologyOutcomes ResearchPublic HealthEffective TherapyBiologicalDesignMutationResistance MechanismEvaluationTranslationsNanotechnology PlatformCancer EtiologyUnited StatesTreatment EfficacyTumorAntibodiesChemotherapyCombinatorialCessation Of LifeSilicon DioxideMortalityGrant
Grant awards (10)
Stimuli-responsive mucin1-specific nanoparticles for efficacious combinatorial chemotherapy of pancreatic ductal adenocarcinoma$489,818
R01 · FY2025 · CA · contact PI
Stimuli-responsive mucin1-specific nanoparticles for efficacious combinatorial chemotherapy of pancreatic ductal adenocarcinoma$442,634
R01 · FY2024 · CA · contact PI
Light-Activated Silver Nanoparticles to Eliminate Antibiotic Resistant Bacteria and Genes$146,622
R16 · FY2024 · GM · contact PI
Light-Activated Silver Nanoparticles to Eliminate Antibiotic Resistant Bacteria and Genes$68,645
R16 · FY2024 · GM · contact PI
Stimuli-responsive mucin1-specific nanoparticles for efficacious combinatorial chemotherapy of pancreatic ductal adenocarcinoma$329,848
R01 · FY2023 · CA · contact PI
Light-Activated Silver Nanoparticles to Eliminate Antibiotic Resistant Bacteria and Genes$146,901
R16 · FY2023 · GM · contact PI
Multimodal hybrid nanoparticles for the treatment of triple-negative breast cancer$450,269
R15 · FY2022 · CA · contact PI
Stimuli-responsive mucin1-specific nanoparticles for efficacious combinatorial chemotherapy of pancreatic ductal adenocarcinoma$349,329
R01 · FY2022 · CA · contact PI
Light-Activated Silver Nanoparticles to Eliminate Antibiotic Resistant Bacteria and Genes$147,066
R16 · FY2022 · GM · contact PI
Multifunctional nanoparticles for combinational therapy of pancreatic cancer$437,210
R15 · FY2015 · CA · contact PI